Common antiplatelet medications include aspirin, which inhibits the enzyme cyclooxygenase-1 (COX-1), and clopidogrel, which blocks the P2Y12 receptor on platelets. By preventing platelets from ...

[75] Since fibrinogen binding to the activated receptor GPIIb/IIIa constitutes the final common pathway of platelet ... The combined use of antiplatelet drugs acting through different mechanisms ...

Ticagrelor costs the United States over $750 million annually, yet a BMJ investigation casts new doubts on the reliability of ...

Antiplatelet drugs have an established role in secondary ... and tachycardia were significantly more common with cilostazol.